rF1V-1018

Phase 2

16%

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

Upcoming Catalysts

May 29

DVAXPhase 2Phase 2

rF1V-1018 Phase 2 Results Expected

rF1V-1018 • Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersenia Pestis

Drug Information

Target Indication

Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersenia Pestis

Clinical Trial

Last updated: 12/4/2025